Non-selective beta-blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection.
Non-selective beta-blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection. Aliment Pharmacol Ther. 2021 02; 53(3):418-425.